Relapse Leukemia: Clinical Trials

4 trials for Relapse Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 12Unknown 2
Phase 31Unknown 1

Follow Relapse Leukemia: new trials by email Literature Review of Relapse Leukemia trials Research Report on Relapse Leukemia

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Allogeneic CD19 CAR-T cells - Relapse Leukemia, Refractory Leukemia
Phase 1 / Phase 2UnknownShenzhen University General Hospital202021-02-052021-12-20
Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia
Decitabine, mBU/CY and ATG, mBU/CY - Stem Cell Transplant Complications, Relapse Leukemia
Phase 2 / Phase 3UnknownPeking University People's Hospital552018-12-012019-05-29
Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)
GLIDE - Hematologic Cancer, Relapse Leukemia
Phase 1 / Phase 2UnknownCiusss de L'Est de l'Île de Montréal202017-02-062017-12-06
Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia
Cladribine, G-CSF, Aclarubicin - Acute Myeloid Leukemia, Relapse Leukemia
Phase 2UnknownSun Yat-sen University482016-01-012019-08-20

Narrower conditions

Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Leukemia (2)  ·  Leukemia, Myeloid (2)  ·  Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)

Interventions

Aclarubicin (1)  ·  Cladribine (1)  ·  Cytarabine (1)  ·  Decitabine (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  aclacinomycins (1)

Sponsors

Ciusss de L'Est de l'Île de Montréal (1)  ·  Peking University People's Hospital (1)  ·  Shenzhen University General Hospital (1)  ·  Sun Yat-sen University (1)

Countries

China (3)  ·  Canada (1)

Top investigators

Denis-Claude Roy, MD PhD (1)  ·  Li Yu, Dr (1)  ·  Liang Wang, M.D. (1)  ·  Silvy Lachance, MD (1)  ·  Xiao-Jun Huang (1)